By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Xenetic Biosciences  

Greener House
66-68 Haymarket
  London  SW1Y 4RF  United Kingdom
Phone: 44-0-20-3021-1500 Fax: 44-0-20-3021-1511


SEARCH JOBS








Company News
Xenetic Biosciences Completes Enrollment Of Second Cohort In Phase 2a Study With Erepoxen® For Anemia; Hemoglobin Levels Rise Into Therapeutic Range Over Time 12/19/2014 11:18:51 AM
Xenetic Biosciences CEO Delivers “2014 – The Year In Review” Update To Investors And Stakeholders 12/18/2014 9:28:47 AM
Xenetic Biosciences Announces OncoHist™ Preclinical Data To Be Featured In A Poster Presentation At The American Society of Hematology Annual Meeting 12/4/2014 9:58:06 AM
Xenetic Biosciences Partner Completes Dosing Of Second Cohort In Phase 2a Study Of Erepoxen® In Patients With Chronic Kidney Disease On Dialysis 12/2/2014 11:35:23 AM
Xenetic Biosciences Provides Update On Substantial Patent Grants And Allowances In U.S. and Worldwide 11/25/2014 9:04:16 AM
Xenetic Biosciences Partner Completes First Patient Cohort In Phase 2 Study With MyeloXen™ For Multiple Sclerosis 11/21/2014 8:29:57 AM
Xenetic Biosciences To Hold Business Update Conference Call September 23 At 6:00 A.M. Eastern Time 9/23/2014 9:42:56 AM
Xenetic Biosciences To Hold Business Update Conference Call September 23 At 6:00 A.M. Eastern Time 9/22/2014 10:13:07 AM
Xenetic Biosciences Announces Ongoing Safety And Efficacy Data From Phase 2 Trial Of Erepoxen(R) 8/11/2014 12:33:21 PM
Xenetic Biosciences Announces Ongoing Safety Data From Phase 2 Trial Of Erepoxen® 6/30/2014 7:56:41 AM
123
//-->